Found 0 matching trials
Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma
PHASE1This is an open-label, phase Ib study evaluating the combination treatment ...
Location
Sun Yat-sen Universitiy Cancer Center
A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor
PHASE1It is a single-arm, open-label, multicenter, phase I trial,aiming at explor...
Location
Multiple Locations
Linperlisib Combined With Chidamide in Patients With PTCL
PHASE1The phase Ib part of this study aims to determine the recommended phase II ...
Location
Affiliated Cancer Hospital of Zhengzhou University
A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma
PHASE4This is a national multicenter, randomized controlled, open, dose-optimized...
Location
Multiple Locations
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
PHASE1This is a multicenter, prospective, open-label, interventional umbrella stu...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL
PHASE2This is a multicenter, open-label, non-randomized, multi-cohort study to ev...
Location
The First Affiliated Hospital with Nanjing Medical University
Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
PHASE1This is a prospective, multicenter, single-arm, pilot study. The aim of thi...
Location
Zhoukou Central Hospital
A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma
PHASE2This is a Phase II/III, international multiple center study to evaluate the...
Location
Multiple Locations
Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)
PHASE1This is a Phase I, multicenter, non-randomized, open-label, dose-explorator...
Location
Multiple Locations
Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
PHASE1This is a prospective, multicenter, open-label, phase Ib/II clinical study ...
Location
Multiple Locations